New Blood Clot Warnings Added to Labels of Testosterone Products

June 21, 2014 12:53 AM

19 0

The US Food and Drug Administration (FDA) yesterday said it will require manufacturers of testosterone products about an increased risk of venous blood clots, known as venous thromboembolism (VTE)—the latest warning for a class of drugs that has seen no shortage of scrutiny from regulators and researchers alike.

Testosterone products, commonly used to treat low levels of testosterone in men, or "low-t," have long been associated with higher risks of some adverse events.

Read more

To category page